Humanetics Grants Exclusive License to iSatori
CHANHASSEN, Minn.--Humanetics Corp. (www.humaneticscorp.com) granted an exclusive worldwide license to iSatori Global Technologies to create and market products containing Humanetics patent-pending technology for increased whole body creatine retention. The technology is based on combining creatine with specific doses of Inzitol, Humanetics proprietary d-pinitol ingredient that acts as a natural insulin mediator.
iSatori is introducing the technology in its product Meta-CEL - Muscle Augmentation System. The product was developed in conjunction with nutritional and exercise biochemist Anthony Almada, who also conducted the studies using Inzitol.